Ambulatory Ritonavir-Boosted Nirmatrelvir and Molnupiravir Associated with Reduced Hospitalization and Death
By Peter A. McCullough, MD, MPH Ritonavir-boosted nirmatrelvir and molnupiravir are currently used in the US and in other countries as part of the McCullough Protocol to treat nonhospitalized patients who have mild-to-moderate COVID-19 and who are at high risk for progression to severe disease. Lin et al from the Cleveland Clinic reported on these […]
Discuss on Nostr!
Nostr Note ID note1fwmkg3sn7wphl9asplz3mtqtgpjc204ccu4yyegyngc7lzekfhqqtvd043 Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.